Source: Benzinga

UNITY: Unity Biotechnology Unveils Mixed Data From Study For Diabetes-Related Blindness, Stock Falls

Unity diabetes study showing durable vision gains with full 36-week data expected in Q2 2025. read more

Read full article »
UNITY's Competitors | UNITY's News | UNITY's Financials
Stay up-to-date with the latest news on UNITY
Annual Revenue
$100K-5.0M
Employees
1-25
Anirvan Ghosh's photo - CEO of UNITY

CEO

Anirvan Ghosh

CEO Approval Rating

58/100

Read more
Stay up-to-date with the latest news on UNITY